| Literature DB >> 35097410 |
Masakazu Tazaki1,2, Takaaki Hirano1, Yui Akiyama1, Hiroyuki Mitsui1, Kazuaki Hirata3, Hisateru Niki1.
Abstract
BACKGROUND: Lateral column lengthening (LCL) for flexible flatfoot is an effective surgery with powerful correction of deformity because it tightens only the lateral third of the long plantar ligament (LPL). However, LCL has been associated with joint damage at the osteotomy site and loss of foot flexibility owing to joint fixation. We focused on the cuboid and investigate a novel anatomical LCL osteotomy site that effectively tightens the LPL without damaging any joints.Entities:
Keywords: cuboid osteotomy; flatfoot; lateral column lengthening
Year: 2020 PMID: 35097410 PMCID: PMC8702912 DOI: 10.1177/2473011420959651
Source DB: PubMed Journal: Foot Ankle Orthop ISSN: 2473-0114
Figure 1.Anatomy of the inferior calcaneocuboid ligament from the plantar view. (A) Overall view. (B) Enlarged view of LPL and SPL. (C) Schematic diagram and measurement items. i, LPL medial length; ii, LPL lateral length; iii, LPL calcaneus attachment width; iv, LPL cuboid attachment width; v, LPL attachment medial length; vi, LPL attachment lateral length; vii, LPL attachment calcaneus width; and viii, LPL attachment cuboid width. Ca, calcaneus; Cu, cuboid; T, talus; N, navicular; C1-3, cuneiform; M1-5, metatarsal; PLT, peroneus longus tendon; LPL, long plantar ligament; SPL, short plantar ligament.
Figure 2.Anatomy of the short plantar ligament after resecting the long plantar ligament. (A) Anatomical chart. (B) Schematic diagram and measurement items. i, SPL medial length; ii, SPL lateral length; iii, SPL calcaneus attachment width; iv, SPL cuboid attachment width. Ca, calcaneus; Cu, cuboid; T, talus; N, navicular; C1-3, cuneiform; M1-5, metatarsal; PLT, peroneus longus tendon; LPL, long plantar ligament; SPL, short plantar ligament.
Figure 3.Distance from the calcaneocuboid joint to the attachment. (A) Anatomical chart. (B) Schematic diagram and measurement items. i, SPL distance to the medial calcaneus attachment; ii, SPL distance to the lateral calcaneus attachment; iii, LPL distance to the medial calcaneus attachment; iv, LPL distance to the lateral calcaneus attachment; v, distance to the medial cuboid attachment; vi, distance to the central cuboid attachment; vii, distance to the lateral cuboid attachment. Ca, calcaneus; Cu, cuboid; T, talus; N, navicular; C1-3, cuneiform; M1-5, metatarsal; PLT, peroneus longus tendon; LPL, long plantar ligament; SPL, short plantar ligament.
Figure 4.Medial facet of the cuboid. (A) Anatomical chart. (B) Schematic diagram and measurement items. i, Distance from the cuboid-metatarsal joint to the cuneocuboid joint; ii, distance from the calcaneocuboid joint to the cuneocuboid joint. α, osteotomy angle; CMJ, cubometatarsal joint; CaCuJ, calcaneocuboid joint; CuCu joint, cuneocuboid joint.
Measurements of the Inferior Calcaneocuboid Ligament.
| Mean, mm | SD | Maximum, mm | Minimum, mm | |||
|---|---|---|---|---|---|---|
| LPL | Length | Medial | 42.7 | 6.9 | 59.2 | 33.4 |
| Lateral | 30.9 | 6.8 | 40.5 | 15.9 | ||
| Width | Calcaneus | 19.2 | 3.6 | 26.0 | 11.2 | |
| Cuboid | 22.9 | 3.1 | 29.2 | 16.9 | ||
| LPL attachment | Length | Medial | 26.9 | 5.4 | 43.2 | 20.4 |
| Lateral | 20.7 | 7.3 | 34.9 | 8.1 | ||
| Width | Calcaneus | 13.1 | 3.4 | 20.5 | 6.7 | |
| Cuboid | 18.6 | 2.8 | 22.3 | 10.7 | ||
| SPL | Length | Medial | 15.9 | 3.2 | 22.2 | 9.2 |
| Lateral | 21.4 | 3.8 | 31.0 | 15.2 | ||
| Width | Calcaneus | 13.6 | 2.8 | 18.0 | 5.7 | |
| Cuboid | 13.6 | 4.1 | 19.2 | 7.2 | ||
Abbreviations: LPL, long plantar ligament; SD, standard deviation; SPL, short plantar ligament.
Distance Between the Calcaneocuboid Joint and Attachment to the Inferior Calcaneocuboid Ligament.
| Mean, mm | SD | Maximum, mm | Minimum, mm | |||
|---|---|---|---|---|---|---|
| Calcaneus | CaCuJ to SPL | Medial | 4.9 | 1.6 | 8.4 | 2.8 |
| Lateral | 5.9 | 2.2 | 9.9 | 2.1 | ||
| CaCuJ to LPL | Medial | 12.6 | 5.4 | 28.2 | 4.7 | |
| Lateral | 14.1 | 6.0 | 26.9 | 6.3 | ||
| Cuboid | CaCuJ to SPL and LPL | Medial | 4.4 | 1.1 | 7.9 | 2.2 |
| Middle | 10.0 | 1.7 | 12.9 | 6.6 | ||
| Lateral | 4.6 | 0.9 | 6.2 | 2.9 | ||
Abbreviations: CaCuJ, calcaneocuboid joint; LPL, long plantar ligament; SD, standard deviation; SPL, short plantar ligament
Location of the Cuneocuboid Joint.
| Mean, mm | SD | Maximum, mm | Minimum, mm | |
|---|---|---|---|---|
| CMJ to CuCuJ | 6.7 | 1.2 | 9.2 | 4.3 |
| CaCuJ to CuCuJ | 4.7 | 2.6 | 8.7 | 0.7 |
Abbreviations: CaCuJ, calcaneocuboid joint; CMJ, cubometatarsal joint; CuCuJ, cuneocuboid joint; SD, standard deviation
Figure 5.Joint on the medial facet of the cuboid. (A) No articular facet with the navicular bone. (B) Articular facet fused with the navicular bone. (C) Articular facet isolated from the navicular bone. (D) Articular facet with the head of talus. Cu, cuneocuboid joint; N, cuboideonavicular joint; T, talocuboid joint.
Sex Comparison.
| Male, mm | Female, mm |
| |||
|---|---|---|---|---|---|
| LPL | Length | Medial | 45.9 | 39.4 | .020 |
| Lateral | 31.6 | 30.1 | .593 | ||
| Width | Calcaneus | 20.8 | 17.6 | .035 | |
| Cuboid | 23.8 | 22.0 | .162 | ||
| LPL attachment | Lengths | Medial | 27.7 | 26.0 | .457 |
| Lateral | 20.2 | 21.1 | .787 | ||
| Widths | Calcaneus | 13.6 | 12.6 | .507 | |
| Cuboid | 19.6 | 17.7 | .096 | ||
| SPL | Lengths | Medial | 16.7 | 15.1 | .255b |
| Lateral | 22.1 | 20.7 | .391b | ||
| Widths | Calcaneus | 14.6 | 12.7 | .104 | |
| Cuboid | 14.7 | 12.5 | .226 | ||
| Calcaneus | CaCuJ to SPL | Medial | 5.8 | 4.0 | .003 |
| Lateral | 6.9 | 4.9 | .030 | ||
| CaCuJ to LPL | Medial | 13.8 | 11.5 | .336 | |
| Lateral | 15.0 | 13.2 | .480 | ||
| Cuboid | CaCuJ to SPL and LPL | Medial | 4.6 | 4.3 | .504 |
| Middle | 10.2 | 9.8 | .534 | ||
| Lateral | 4.9 | 4.4 | .130 | ||
| CMJ to CuCuJ | 7.1 | 6.2 | .073 | ||
| CaCuJ to CuCuJ | 3.5 | 6.0 | .021 | ||
| Bone cutting angle | 11.2 | 9.4 | .300 | ||
Abbreviations: CaCuJ, calcaneocuboid joint; CMJ, cubometatarsal joint; CuCuJ, cuneocuboid joint; LPL, long plantar ligament; SPL, short plantar ligament.
a Student t test, unless otherwise noted.
bWelch t test.
Figure 6.Osteotomy line. Osteotomy in a straight line connecting a point 4 mm from the calcaneocuboid joint laterally and a point 6 mm from the cuboid-metatarsal joint medially at a 10-degree posterior tilt to the cuboid-metatarsal joint.
STROBE Statement—Checklist of Items That Should Be Included in Reports of Observational Studies.a
| Item No. | Recommendation | Page No. | |
|---|---|---|---|
|
| 1 | ( | 1-2 |
| ( | 1-2 | ||
| Introduction | |||
| Background/rationale | 2 | Explain the scientific background and rationale for the investigation being reported | 3-4 |
| Objectives | 3 | State specific objectives, including any prespecified hypotheses | 4 |
| Methods | |||
| Study design | 4 | Present key elements of study design early in the paper | 4-6 |
| Setting | 5 | Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collection | 4-6 |
| Participants | 6 | ( | NA |
| ( | NA | ||
| Variables | 7 | Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable | NA |
| Data sources/measurement | 8b | For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group |
|
| Bias | 9 | Describe any efforts to address potential sources of bias | NA |
| Study size | 10 | Explain how the study size was arrived at | NA |
| Quantitative variables | 11 | Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why | NA |
| Statistical methods | 12 | ( | 6 |
| ( | NA | ||
| ( | NA | ||
| ( | NA | ||
| ( | NA | ||
| Results | |||
| Participants | 13b | (a) Report numbers of individuals at each stage of study—eg numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed | 6-8 |
| (b) Give reasons for non-participation at each stage | NA | ||
| (c) Consider use of a flow diagram | NA | ||
| Descriptive data | 14b | (a) Give characteristics of study participants (eg demographic, clinical, social) and information on exposures and potential confounders | NA |
| (b) Indicate number of participants with missing data for each variable of interest | NA | ||
| (c) | NA | ||
| Outcome data | 15b |
| NA |
|
| NA | ||
|
| NA | ||
| Main results | 16 | ( | 8 |
| ( | NA | ||
| ( | NA | ||
| Other analyses | 17 | Report other analyses done—eg analyses of subgroups and interactions, and sensitivity analyses | NA |
| Discussion | |||
| Key results | 18 | Summarise key results with reference to study objectives | 8-9 |
| Limitations | 19 | Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias | NA |
| Interpretation | 20 | Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence | 8-11 |
| Generalisability | 21 | Discuss the generalisability (external validity) of the study results | 11-12 |
| Other information | |||
| Funding | 22 | Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based | NA |
a An Explanation and Elaboration article discusses each checklist item and gives methodological background and published examples of transparent reporting. The STROBE checklist is best used in conjunction with this article (freely available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine at http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is available at www.strobe-statement.org.
bGive information separately for cases and controls in case-control studies and, if applicable, for exposed and unexposed groups in cohort and cross-sectional studies.